Latest Financial Guidance News

Pureprofile Limited has reported a robust Q3 FY25 with revenue up 16% and EBITDA up 16% year-on-year, driving a 20% increase in year-to-date revenue and a 35% jump in EBITDA. The company’s international expansion and new AI-driven solutions underpin its confident outlook for FY25.

Althea Group Holdings has sharply downgraded its FY25 financial guidance, citing significant challenges in its medicinal cannabis division and the strategic withdrawal from a vape product initiative. Despite the setback, the company highlights ongoing growth in its recreational cannabis operations and a strategic refocus on capital efficiency.

Ramsay Health Care has announced a significant $305 million impairment in its UK segment driven by challenges at Elysium, alongside a $64.5 million tax provision release linked to Ramsay Santé. The company is taking decisive steps to address operational weaknesses while its core UK hospitals show promising growth.

PEXA Group Limited has updated its half-year guidance, flagging a $15 million non-cash impairment and a significant increase in tax expenses due to deferred tax asset derecognition.

Tower Limited has raised its full-year underlying NPAT guidance to $60m-$70m, citing strong first-quarter results and favourable claims trends despite softer premium growth.

IVE Group Limited has scheduled its half-year financial results release for February 24, 2025, alongside a notable governance change with Paul Selig moving from Executive to Non-Executive Director.

Doctor Care Anywhere delivered positive cash flow and revenue growth at the top of guidance in Q4 2024, while navigating a strategic shift with new leadership appointments and the closure of secondary care pathways.

Adriatic Metals delivered a strong Q4 2024 with 934koz silver equivalent produced, setting the stage for commercial production at Rupice Mine in Q1 2025. The company’s financial footing and expansion plans signal confidence in scaling operations.

Whitehaven Coal delivered a robust Q2 FY25 with record sales volumes and production costs at the low end of guidance, while preparing for a major $1.08 billion capital inflow from its Blackwater mine stake sale.

Pureprofile Limited has upgraded its FY25 financial guidance following a robust first half, highlighted by a 22% revenue increase and a 30% surge in Q2, driven by strong international expansion and automation adoption.

Biome Australia Limited has expanded its distribution footprint to over 6,000 health retail and practitioner locations, marking a 20% increase in six months and advancing toward its Vision 27 target of 8,000 sites by FY27.